Skip to main content

Table 1 Characteristics of the overall patient cohort (n = 102).

From: Centrilobular emphysema combined with pulmonary fibrosis results in improved survival

Age, years, median [1st, 3rd] 61 [55, 66]
Gender:  




Male, n 66




Female, n 36
Race:  




Caucasian, n 69




African-American, n 28




Other, n 5
Medication:  




Prednisone, n 88




Azathioprine, n 49




Mycophenolate, n 27




N-Acetylcysteine, n 42




ACE Inhibitor, n 19




Statin, n 45
Smoking history:  




Never, n (%) 31 (30)




Ever, n (%) 71 (70)
Right heart catheterization:  




Performed, n (%) 76 (75)




PH present, n (%) 31 (41)
Surgical lung biopsy:  




Performed, n (%) 73 (71)




UIP, n 60




Fibrotic NSIP, n 13
Pulmonary function tests:  




FVC [% predicted; median (1st, 3rd)] 54 [42, 66]




TLC [% predicted; median (1st, 3rd)] 54 [42, 64]




DLCO [% predicted; median (1st, 3rd)] 28 [20, 36]
  1. PH, pulmonary hypertension (defined by mean pulmonary artery pressure > 25 mm Hg); UIP, usual interstitial pneumonia; NSIP, non-specific interstitial pneumonia; FVC, forced vital capacity; TLC, total lung capacity; DLCO, diffusing capacity for carbon monoxide.